MBGYY Financial Statements & Analysis
Complete financial statements for MBGYY including income statement, balance sheet, and cash flow statement. Analyze MBGYY's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
53
Neutral
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
-5.0% ↓
Net Income
-28.4% ↓
Gross Margin
-12.5% ↓
Operating Margin
-2.4% ↓
Balance Sheet
Current Ratio
8.9% ↑
Debt to Equity
5.7% ↓
Asset Turnover
-5.7% ↓
Cash Flow
Operating Cash Flow
22.6% ↑
Net Cash Flow
14.7% ↑
Free Cash Flow
45.0% ↑
Cash Flow to Debt
14.9% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2023 | 2024 | Change | Impact |
|---|---|---|---|---|
| Revenue | 153.22B | 145.59B | 5.0% | |
| Gross Profit | 34.38B | 28.58B | 16.9% | |
| Operating Income | 13.27B | 12.30B | 7.3% | |
| Net Income | 14.26B | 10.21B | 28.4% | |
| EPS | 3.37 | 2.55 | 24.3% | |
| EBITDA | 27.44B | 21.50B | 21.6% | |
| Gross Margin | 22.44% | 19.63% | 12.5% | |
| Operating Margin | 8.66% | 8.45% | 2.4% | |
| Net Income Margin | 9.31% | 7.01% | 24.7% | |
| R&D Expenses | 8.37B | 5.58B | 33.3% |
Income Statement Full Table
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 145.59B | 153.22B | 150.02B | 133.89B | 154.31B |
| Gross Profit | 28.58B | 34.38B | 34.02B | 30.68B | 25.59B |
| Operating Income | 12.30B | 13.27B | 20.28B | 16.93B | 6.95B |
| Net Income | 10.21B | 14.26B | 14.50B | 11.05B | 3.63B |
| EPS | 2.55 | 3.37 | 3.39 | 0.65 | 0.21 |
| EBITDA | 21.50B | 27.44B | 27.25B | 23.22B | 15.39B |
| Gross Margin | 19.63% | 22.44% | 22.68% | 22.91% | 16.58% |
| Operating Margin | 8.45% | 8.66% | 13.52% | 12.65% | 4.51% |
| Net Income Margin | 7.01% | 9.31% | 9.67% | 8.25% | 2.35% |
| R&D Expenses | 5.58B | 8.37B | 5.60B | 5.47B | 6.12B |